Abbvie Inc. - Net Worth and Insider Trading
Abbvie Inc. Net Worth
The estimated net worth of Abbvie Inc. is at least $205 Million dollars as of 2025-01-01. Abbvie Inc. is the 10% Owner of Reata Pharmaceuticals Inc and owns about 1,190,473 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $205 Million. Details can be seen in Abbvie Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Abbvie Inc. has not made any transactions after 2017-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Abbvie Inc.
Abbvie Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Abbvie Inc. owns 1 companies in total, including Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Abbvie Inc.’s form 4 insider trades.
Insider Ownership Summary of Abbvie Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2017-03-28 | 10 percent owner |
Abbvie Inc. Latest Holdings Summary
Abbvie Inc. currently owns a total of 1 stock. Abbvie Inc. owns 1,190,473 shares of Reata Pharmaceuticals Inc (RETA) as of March 28, 2017, with a value of $205 Million.
Latest Holdings of Abbvie Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2017-03-28 | 1,190,473 | 172.36 | 205,189,926 |
Holding Weightings of Abbvie Inc.
Abbvie Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Abbvie Inc. has made a total of 0 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 450,000 shares on March 28, 2017, which brought Abbvie Inc. around $10 Million.
Insider Trading History of Abbvie Inc.
- 1
Abbvie Inc. Trading Performance
Abbvie Inc. Ownership Network
Abbvie Inc. Owned Company Details
What does Reata Pharmaceuticals Inc do?
Who are the key executives at Reata Pharmaceuticals Inc?
Abbvie Inc. is the 10 percent owner of Reata Pharmaceuticals Inc. Other key executives at Reata Pharmaceuticals Inc include director & 10 percent owner Antal Rohit Desai , SVP & Chief Accounting Officer Bhaskar Anand , and EVP & Chief R&D Officer Rajiv Patni .
Reata Pharmaceuticals Inc (RETA) Insider Trades Summary
Over the past 18 months, Abbvie Inc. made no insider transaction in Reata Pharmaceuticals Inc (RETA). Other recent insider transactions involving Reata Pharmaceuticals Inc (RETA) include a net sale of 76,755 shares made by Manmeet Singh Soni , a net sale of 41,205 shares made by Dawn Carter Bir , and a net sale of 809 shares made by Bhaskar Anand .
In summary, during the past 3 months, insiders sold 0 shares of Reata Pharmaceuticals Inc (RETA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,124 shares of Reata Pharmaceuticals Inc (RETA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,124 shares.
Reata Pharmaceuticals Inc (RETA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reata Pharmaceuticals Inc Insider Transactions
Abbvie Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Abbvie Inc.. You might contact Abbvie Inc. via mailing address: 1 North Waukegan Road, North Chicago Il 60064.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
